Rafferty Asset Management’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$606K Sell
105,110
-25,988
-20% -$150K ﹤0.01% 845
2025
Q1
$865K Sell
131,098
-14,516
-10% -$95.8K ﹤0.01% 771
2024
Q4
$1.27M Buy
145,614
+53,877
+59% +$469K ﹤0.01% 745
2024
Q3
$1.79M Sell
91,737
-32,848
-26% -$642K 0.01% 671
2024
Q2
$2.57M Sell
124,585
-186,683
-60% -$3.84M 0.01% 577
2024
Q1
$6.64M Buy
311,268
+159,994
+106% +$3.41M 0.02% 397
2023
Q4
$2.18M Sell
151,274
-80,933
-35% -$1.16M 0.01% 652
2023
Q3
$2.12M Buy
232,207
+34,574
+17% +$315K 0.01% 598
2023
Q2
$2.09M Sell
197,633
-76,921
-28% -$814K 0.01% 629
2023
Q1
$3.36M Sell
274,554
-53,364
-16% -$653K 0.02% 480
2022
Q4
$4.07M Buy
327,918
+46,004
+16% +$571K 0.03% 420
2022
Q3
$3.85M Buy
281,914
+186,640
+196% +$2.55M 0.04% 378
2022
Q2
$1.75M Sell
95,274
-85,809
-47% -$1.57M 0.02% 506
2022
Q1
$2.91M Sell
181,083
-27,887
-13% -$448K 0.02% 515
2021
Q4
$2.93M Buy
208,970
+91,758
+78% +$1.28M 0.02% 544
2021
Q3
$2.2M Buy
117,212
+864
+0.7% +$16.2K 0.02% 615
2021
Q2
$2.43M Buy
116,348
+3,406
+3% +$71K 0.02% 620
2021
Q1
$3.19M Buy
112,942
+90,544
+404% +$2.56M 0.02% 450
2020
Q4
$732K Sell
22,398
-6,207
-22% -$203K 0.01% 597
2020
Q3
$876K Buy
28,605
+16,111
+129% +$493K 0.01% 594
2020
Q2
$204K Buy
+12,494
New +$204K ﹤0.01% 926
2020
Q1
Sell
-21,551
Closed -$296K 717
2019
Q4
$296K Sell
21,551
-38,307
-64% -$526K ﹤0.01% 793
2019
Q3
$908K Buy
59,858
+38,409
+179% +$583K 0.01% 563
2019
Q2
$422K Sell
21,449
-9,079
-30% -$179K 0.01% 718
2019
Q1
$506K Buy
+30,528
New +$506K 0.01% 670